Sign in

CIK 0000948320

  • Accelerated filer

LifeMD, Inc.

Sign in to watch
Ticker
LFMD
Exchange
Nasdaq
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760238453
Phone
+1 866-351-5907
Business address
236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
Former names
CONVERSION LABS, INC., Immudyne, Inc.

Securities

  • LFMD Common Stock Nasdaq
  • LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Chief Executive Officer bought 13,900 shares at $0.15 ($2,016)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy Chief Executive Officer bought 75,000 shares at an average $0.17 ($12,494)
  5. 4 Open-market buy Director bought 200,000 shares at an average $0.18 ($36,180)
  6. 4 Open-market buy Chief Executive Officer bought 49,487 shares at $0.17 ($8,561)
  7. 4 Open-market buy Chief Executive Officer bought 74,128 shares at an average $0.16 ($11,826)
  8. 4 Gift Chief Executive Officer gave 100,000 shares (gift)
  9. 4 Open-market buy Director bought 25,000 shares at an average $0.12 ($3,119)
  10. 4 Open-market buy Director bought 69,000 shares at an average $0.13 ($8,957)
  11. 4 Open-market buy Director bought 25,000 shares at $0.12 ($3,000)
  12. 4 Open-market buy Director bought 54,965 shares at an average $0.13 ($7,177)
  13. 4 Open-market buy Chief Executive Officer bought 50,000 shares at $0.13 ($6,500)
  14. 4 Open-market buy Director bought 51,035 shares at an average $0.14 ($7,029)
  15. 4 Open-market buy Chief Operating Officer bought 4,687 shares at $0.16 ($750)
  16. 4 Open-market buy Chief Executive Officer bought 25,000 shares at an average $0.10 ($2,489)
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 10 of 12 · 230 filings